Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding

Virology Journal

Volumn 5, Issue , 2008, Pages

  Rothwangl, Katharina B ^a   Manicassamy, Balaji ^a,b   Uprichard, Susan L ^a   Rong, Lijun ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; LEUKOCYTE ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ANTIGEN BINDING; ARTICLE; CELL LINE; CELL LYSATE; EMBRYO; GENE MUTATION; GENETIC ASSOCIATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PARTICLE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMISTRY; GENETICS; HYDROPHOBICITY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN MOTIF; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

HEPATITIS C VIRUS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENS, CD; CELL LINE; CONSERVED SEQUENCE; GENES, REPORTER; HEPACIVIRUS; HUMANS; HYDROPHOBICITY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 41549117544     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-46     Document Type: Article

References (56)

1. Flaviviridae: The viruses and their replication. BD Lindenbach CM Rice, Field's Virology Philadelphia, Pippincott Williams & Wilkins, Knipe DM and Howley PM, 4th 2001 2 991 1041
2. Assembly of a functional HCV glycoprotein heterodimer. M Lavie A Goffard J Dubuisson, Curr Issues Mol Biol 2007 9 71 86 17489436
3. Binding of hepatitis C virus to CD81. P Pileri Y Uematsu S Campagnoli G Galli F Falugi R Petracca AJ Weiner M Houghton D Rosa G Grandi S Abrignani, Science 1998 282 938 941 10.1126/science.282.5390.938 9794763
4. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. A Meola A Sbardellati B Bruni Ercole M Cerretani M Pezzanera A Ceccacci A Vitelli S Levy A Nicosia C Traboni J McKeating E Scarselli, J Virol 2000 74 5933 5938 10846074 10.1128/JVI.74.13. 5933-5938.2000
5. Diverse CD81 proteins support hepatitis C virus infection. M Flint T von Hahn J Zhang M Farquhar CT Jones P Balfe CM Rice JA McKeating, J Virol 2006 80 11331 11342 16943299 10.1128/JVI.00104-06
6. CD81 is an entry coreceptor for hepatitis C virus. EG Cormier F Tsamis F Kajumo RJ Durso JP Gardner T Dragic, Proc Natl Acad Sci U S A 2004 101 7270 7274 15123813 10.1073/pnas.0402253101
7. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. E Scarselli H Ansuini R Cerino RM Roccasecca S Acali G Filocamo C Traboni A Nicosia R Cortese A Vitelli, Embo J 2002 21 5017 5025 12356718 10.1093/emboj/cdf529
8. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. P Maillard T Huby U Andreo M Moreau J Chapman A Budkowska, Faseb J 2006 20 735 737 16476701
9. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. C Voisset N Callens E Blanchard A Op De Beeck J Dubuisson N Vu-Dac, J Biol Chem 2005 280 7793 7799 10.1074/jbc.M411600200 15632171
10. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. V Agnello G Abel M Elfahal GB Knight QX Zhang, Proc Natl Acad Sci U S A 1999 96 12766 12771 10535997 10.1073/pnas.96.22.12766
11. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. M Monazahian I Bohme S Bonk A Koch C Scholz S Grethe R Thomssen, J Med Virol 1999 57 223 229 10.1002/(SICI)1096-9071(199903)57:3<223::AID- JMV2〉3.0.CO;2-4 10022791
12. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. MJ Evans T von Hahn DM Tscherne AJ Syder M Panis B Wolk T Hatziioannou JA McKeating PD Bieniasz CM Rice, Nature 2007 446 801 805 10.1038/nature05654 17325668
13. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. A Zheng F Yuan Y Li F Zhu P Hou J Li X Song M Ding H Deng, J Virol 2007 81 12465 12471 17804490 10.1128/JVI.01457-07
14. Effect of cell polarization on hepatitis C virus viral entry. CJ Mee J Grove HJ Harris K Hu P Balfe JA McKeating, J Virol 2007 17959672
15. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. S Pohlmann J Zhang F Baribaud Z Chen GJ Leslie G Lin A Granelli-Piperno RW Doms CM Rice JA McKeating, J Virol 2003 77 4070 4080 12634366 10.1128/JVI.77.7.4070- 4080.2003
16. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. H Barth A Ulsenheimer GR Pape HM Diepolder M Hoffmann C Neumann-Haefelin R Thimme P Henneke R Klein G Paranhos-Baccala E Depla TJ Liang HE Blum TF Baumert, Blood 2005 105 3605 3614 10.1182/blood-2004-05-1952 15657184
17. DC-SIGN: escape mechanism for pathogens. Y van Kooyk TB Geijtenbeek, Nat Rev Immunol 2003 3 697 709 10.1038/nri1182 12949494
18. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. EG Cormier RJ Durso F Tsamis L Boussemart C Manix WC Olson JP Gardner T Dragic, Proc Natl Acad Sci U S A 2004 101 14067 14072 15371595 10.1073/pnas.0405695101
19. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. PY Lozach A Amara B Bartosch JL Virelizier F Arenzana-Seisdedos FL Cosset R Altmeyer, J Biol Chem 2004 279 32035 32045 10.1074/jbc.M402296200 15166245
20. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. A Rigotti HE Miettinen M Krieger, Endocr Rev 2003 24 357 387 10.1210/er.2001-0037 12788804
21. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. SB Kapadia H Barth T Baumert JA McKeating FV Chisari, J Virol 2007 81 374 383 17050612 10.1128/JVI.01134-06
22. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. B Bartosch A Vitelli C Granier C Goujon J Dubuisson S Pascale E Scarselli R Cortese A Nicosia FL Cosset, J Biol Chem 2003 278 41624 41630 10.1074/jbc.M305289200 12913001
23. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein. TH Heo SM Lee B Bartosch FL Cosset CY Kang, Virus Res 2006 121 58 64 10.1016/j.virusres.2006.04.002 16725222
24. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. S Levy SC Todd HT Maecker, Annu Rev Immunol 1998 16 89 109 10.1146/annurev.immunol.16.1.89 9597125
25. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2. HE Drummer KA Wilson P Poumbourios, Biochem Biophys Res Commun 2005 328 251 257 10.1016/j.bbrc.2004.12.160 15670777
26. CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. K Kitadokoro D Bordo G Galli R Petracca F Falugi S Abrignani G Grandi M Bolognesi, Embo J 2001 20 12 18 11226150 10.1093/emboj/20.1.12
27. Tetraspanins in viral infections: a fundamental role in viral biology? F Martin DM Roth DA Jans CW Pouton LJ Partridge PN Monk GW Moseley, J Virol 2005 79 10839 10851 16103137 10.1128/JVI.79.17.10839-10851.2005
28. Tetraspanin functions and associated microdomains. ME Hemler, Nat Rev Mol Cell Biol 2005 6 801 811 10.1038/nrm1736 16314869
29. Complete replication of hepatitis C virus in cell culture. BD Lindenbach MJ Evans AJ Syder B Wolk TL Tellinghuisen CC Liu T Maruyama RO Hynes DR Burton JA McKeating CM Rice, Science 2005 309 623 626 10.1126/science.1114016 15947137
30. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao K Murthy A Habermann HG Krausslich M Mizokami R Bartenschlager TJ Liang, Nat Med 2005 11 791 796 10.1038/nm1268 15951748
31. Robust hepatitis C virus infection in vitro. J Zhong P Gastaminza G Cheng S Kapadia T Kato DR Burton SF Wieland SL Uprichard T Wakita FV Chisari, Proc Natl Acad Sci U S A 2005 102 9294 9299 15939869 10.1073/pnas.0503596102
32. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. BD Lindenbach P Meuleman A Ploss T Vanwolleghem AJ Syder JA McKeating RE Lanford SM Feinstone ME Major G Leroux-Roels CM Rice, Proc Natl Acad Sci U S A 2006 103 3805 3809 16484368 10.1073/pnas.0511218103
33. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. A Higginbottom ER Quinn CC Kuo M Flint LH Wilson E Bianchi A Nicosia PN Monk JA McKeating S Levy, J Virol 2000 74 3642 3649 10729140 10.1128/JVI.74.8.3642-3649.2000
34. Structure-function analysis of hepatitis C virus envelope-CD81 binding. R Petracca F Falugi G Galli N Norais D Rosa S Campagnoli V Burgio E Di Stasio B Giardina M Houghton S Abrignani G Grandi, J Virol 2000 74 4824 4830 10775621 10.1128/JVI.74.10.4824-4830.2000
35. A model for the hepatitis C virus envelope glycoprotein E2. AT Yagnik A Lahm A Meola RM Roccasecca BB Ercole A Nicosia A Tramontano, Proteins 2000 40 355 366 10.1002/1097-0134(20000815)40:3<355::AID-PROT20〉3.0.CO;2-K 10861927
36. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. R Roccasecca H Ansuini A Vitelli A Meola E Scarselli S Acali M Pezzanera BB Ercole J McKeating A Yagnik A Lahm A Tramontano R Cortese A Nicosia, J Virol 2003 77 1856 1867 12525620 10.1128/JVI.77.3.1856-1867.2003
37. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. A Owsianka RF Clayton LD Loomis-Price JA McKeating AH Patel, J Gen Virol 2001 82 1877 1883 11457993
38. Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. RF Clayton A Owsianka J Aitken S Graham D Bhella AH Patel, J Virol 2002 76 7672 7682 12097581 10.1128/JVI.76.15.7672-7682.2002
39. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. M Flint JM Thomas CM Maidens C Shotton S Levy WS Barclay JA McKeating, J Virol 1999 73 6782 6790 10400776
40. How does hepatitis C virus enter cells? G Diedrich, Febs J 2006 273 3871 3885 10.1111/j.1742-4658.2006.05379.x 16934030
41. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus. JM Christie H Chapel RW Chapman WM Rosenberg, Hepatology 1999 30 1037 1044 10.1002/hep.510300403 10498657
42. Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses. T Rai M Caffrey L Rong, J Virol 2005 79 14962 14966 16282495 10.1128/JVI.79.23.14962-14966.2005
43. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. A Goffard N Callens B Bartosch C Wychowski FL Cosset C Montpellier J Dubuisson, J Virol 2005 79 8400 8409 15956584 10.1128/JVI.79.13. 8400-8409.2005
44. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. J Dubuisson, Curr Top Microbiol Immunol 2000 242 135 148 10592659
45. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. M Law T Maruyama J Lewis E Giang AW Tarr Z Stamataki P Gastaminza FV Chisari IM Jones RI Fox JK Ball JA McKeating NM Kneteman DR Burton, Nat Med 2008 14 25 27 10.1038/nm1698 18064037
46. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. L Cocquerel JC Meunier A Pillez C Wychowski J Dubuisson, J Virol 1998 72 2183 2191 9499075
47. Characterization of functional hepatitis C virus envelope glycoproteins. A Op De Beeck C Voisset B Bartosch Y Ciczora L Cocquerel Z Keck S Foung FL Cosset J Dubuisson, J Virol 2004 78 2994 3002 14990718 10.1128/JVI.78.6.2994- 3002.2004
48. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. HE Drummer P Poumbourios, J Biol Chem 2004 279 30066 30072 10.1074/jbc.M405098200 15136562
49. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. V Sandrin P Boulanger F Penin C Granier FL Cosset B Bartosch, J Gen Virol 2005 86 3189 3199 10.1099/vir.0.81428-0 16298963
50. Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. Y Ciczora N Callens C Montpellier B Bartosch FL Cosset A Op de Beeck J Dubuisson, J Gen Virol 2005 86 2793 2798 10.1099/vir.0.81140-0 16186234
51. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. Y Ciczora N Callens F Penin EI Pecheur J Dubuisson, J Virol 2007 81 2372 2381 17166909 10.1128/JVI.02198-06
52. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. M Yi Y Nakamoto S Kaneko T Yamashita S Murakami, Virology 1997 231 119 129 10.1006/viro.1997.8516 9143310
53. Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2. L Cocquerel JC Meunier A Op de Beeck D Bonte C Wychowski J Dubuisson, J Gen Virol 2001 82 1629 1635 11413374
54. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. AM Owsianka JM Timms AW Tarr RJ Brown TP Hickling A Szwejk K Bienkowska-Szewczyk BJ Thomson AH Patel JK Ball, J Virol 2006 80 8695 8704 16912317 10.1128/JVI.00271-06
55. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. D Lavillette EI Pecheur P Donot J Fresquet J Molle R Corbau M Dreux F Penin FL Cosset, J Virol 2007 81 8752 8765 17537855 10.1128/JVI.02642-06
56. Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. L Cocquerel ER Quinn M Flint KG Hadlock SK Foung S Levy, J Virol 2003 77 1604 1609 12502876 10.1128/JVI.77.2.1604-1609.2003